{"id":252,"date":"2014-12-15T08:55:15","date_gmt":"2014-12-15T08:55:15","guid":{"rendered":"http:\/\/www.farmacovigilanciacanarias.org\/noticias\/?p=252"},"modified":"2014-12-15T08:55:15","modified_gmt":"2014-12-15T08:55:15","slug":"nota-informativa-muh-fv-182014","status":"publish","type":"post","link":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/2014\/12\/15\/nota-informativa-muh-fv-182014\/","title":{"rendered":"Nota Informativa MUH (FV), 18\/2014"},"content":{"rendered":"<p><a href=\"http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/seguridad\/2014\/NI-MUH_FV_18-leuprorelina.htm\">Eligard\u00ae (leuprorelina): falta de eficacia cl\u00ednica debida a errores durante el proceso de reconstituci\u00f3n y administraci\u00f3n del medicamento<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eligard\u00ae (leuprorelina): falta de eficacia cl\u00ednica debida a errores durante el proceso de reconstituci\u00f3n y administraci\u00f3n del medicamento<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-252","post","type-post","status-publish","format-standard","hentry","category-seguridad"],"_links":{"self":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/comments?post=252"}],"version-history":[{"count":1,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/252\/revisions"}],"predecessor-version":[{"id":253,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/252\/revisions\/253"}],"wp:attachment":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/media?parent=252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/categories?post=252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/tags?post=252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}